Alector (ALEC) Non Operating Income (2018 - 2026)
Alector (ALEC) reported Non Operating Income of $2.0 million for Q1 2026, down 52.91% year-over-year from $4.2 million in Q1 2025, and down 19.38% quarter-over-quarter from $2.5 million in Q4 2025.
Alector (ALEC) Non Operating Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Non Operating Income data on file, last reported at $2.0 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $2.0 million, down 52.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 million (down 51.42% YoY), and the FY2025 annual result was $13.2 million, down 49.2% from the prior year.
- Non Operating Income declined to $2.0 million in Q1 2026 per ALEC's latest filing, from $2.5 million in the prior quarter.
- Over five years, Non Operating Income peaked at $7.7 million in Q4 2023 and troughed at $264000.0 in Q1 2022.
- A 5-year average of $4.4 million and a median of $4.2 million in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2026: Non Operating Income surged 2983.47% in 2022, then tumbled 52.91% in 2026.
- A 5-year view of Non Operating Income shows it stood at $3.7 million in 2022, then surged by 105.98% to $7.7 million in 2023, then tumbled by 32.04% to $5.2 million in 2024, then sank by 52.77% to $2.5 million in 2025, then fell by 19.38% to $2.0 million in 2026.
- Business Quant data shows ALEC's Non Operating Income at $2.0 million in Q1 2026, $2.5 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 6.21 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 7.69 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 3.73 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 178,000.00 |